Publicações

Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, Hiv-1-Infected Adults: 48-Week Results From the Assert Study

AuthID
P-003-3H6

Author(s)

Post, FA

Moyle, GJ

Stellbrink, HJ

Domingo, P

Fisher, M

Rieger, A

Branco, T

Pearce, HC

Givens, N

Vavro, C

Lim, ML

Tipo de Documento

Article

Year published

2010

Publicado

in JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, ISSN: 1525-4135

Volume: 55, Número: 1, Páginas: 49-57 (9)

Conference

12Th European Aids Conference/European-Aids-Clinical-Society (Eacs), Date: NOV 11-24, 2009, Location: Cologne, GERMANY, Patrocinadores: European AIDS Clin Soc

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1097/qai.0b013e3181dd911e

Pubmed: 20431394

SCOPUS: 2-s2.0-77956637582

Wos: WOS:000281170500006

Source Identifiers

ISSN: 1525-4135

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, Hiv-1-Infected Adults: 48-Week Results From the Assert Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, Hiv-1-Infected Adults: 48-Week Results From the Assert Study

Links Úteis

Ajuda